TD Cowen Maintains Buy on Certara, Raises Price Target to $11
TD Cowen analyst Brendan Smith maintains Certara (NASDAQ:CERT) with a Buy and raises the price target from $9 to $11.
Stocks · News reference
Keybanc Maintains Overweight on Certara, Raises Price Target to $12
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Maintains Equal-Weight on Certara, Raises Price Target to $9
Barclays analyst Luke Sergott maintains Certara (NASDAQ:CERT) with a Equal-Weight and raises the price target from $7.5 to $9.
'HHS launches project to speed up clinical trials' - Axios